5,6-Methylenedioxy-2-aminoindane : from laboratory curiosity to 'legal high'
                
    Gallagher, C. T., Assi, S., Stair, J. L., Fergus, S., Corazza, Ornella, Corkery, John and Schifano, Fabrizio
  
(2012)
5,6-Methylenedioxy-2-aminoindane : from laboratory curiosity to 'legal high'.
    Human Psychopharmacology: Clinical and Experimental (2).
     pp. 106-112.
     ISSN 1099-1077
  
  
              
            
The fully synthetic 'legal high' 5,6-methylenedioxy-2-aminoindane (MDAI) is an analogue of 3,4-methylenedioxymethamphetamine. Although developed in the 1990s, it was not widely abused until 2010. However, mephedrone was banned in the UK in April 2010, and almost immediately, MDAI was widely advertised as a legal alternative. This paper provides both an overview of the current state of knowledge of MDAI and a critical analysis of online available information relating to its psychoactive effects, adverse reactions and use in combination with other drugs.
| Item Type | Article | 
|---|---|
| Date Deposited | 29 May 2025 09:07 | 
| Last Modified | 29 May 2025 09:07 |